The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release

Araque, 1998, Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons, Eur. J. Neurosci., 10, 2129, 10.1046/j.1460-9568.1998.00221.x Araque, 1999, Tripartite synapses: glia, the unacknowledged partner, Trends Neurosci., 22, 208, 10.1016/S0166-2236(98)01349-6 Banati, 2002, Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation?, J. Physiol. Paris, 96, 289, 10.1016/S0928-4257(02)00018-9 Bland, 2004, Stress potentiation of morphine-induced dopamine efflux in the nucleus accumbens shell is dependent upon stressor uncontrollability and is mediated by the dorsal raphe nucleus, Neuroscience, 126, 705, 10.1016/j.neuroscience.2004.04.025 Compton, 2006, Major increases in opioid analgesic abuse in the United States: concerns and strategies, Drug Alcohol Depend, 81, 103, 10.1016/j.drugalcdep.2005.05.009 De Vries, 1999, Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration, Psychopharmacology (Berl.), 143, 254, 10.1007/s002130050944 Di Chiara, 2007, Reward system and addiction: what dopamine does and doesn’t do, Curr. Opin. Pharmacol., 7, 69, 10.1016/j.coph.2006.11.003 Dyke, 2002, Update on the therapeutic potential of PDE4 inhibitors, Expert Opin. Investig. Drugs, 11, 1, 10.1517/13543784.11.1.1 Fdez Espejo, 1995, Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed “etho-score”, Psychopharmacology (Berl.), 122, 122, 10.1007/BF02246086 Fitzgerald, 1996, Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents, J. Neurosci., 16, 274, 10.1523/JNEUROSCI.16-01-00274.1996 Gellert, 1978, Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions, J. Pharmacol. Exp. Ther., 205, 536 Gholami, 2003, Nitric oxide within the ventral tegmental area is involved in mediating morphine reward, Eur. J. Pharmacol., 458, 119, 10.1016/S0014-2999(02)02696-1 Hamdy, 2001, A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice, Behav. Brain Res., 118, 85, 10.1016/S0166-4328(00)00315-6 Harris, 1994, Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome, Nature, 371, 155, 10.1038/371155a0 Hutchinson, 2007, Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward, Sci. World J., 7, 98, 10.1100/tsw.2007.230 Hutchinson, M.R., Lewis, S.S., Coats, B.D., Skyba, D.A., Crysdale, N.Y., Berkelhammer, D.L., Brzeski, A., Northcutt, A., Vietz, C.M., Judd, C.M., Maier, S.F., Watkins, L.R., Johnson, K.W., 2009. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav. Immun. 23, 240–250. Hyman, 2006, Neural mechanisms of addiction: the role of reward-related learning and memory, Annu. Rev. Neurosci., 29, 565, 10.1146/annurev.neuro.29.051605.113009 Itoh, 1998, A therapeutic strategy to prevent morphine dependence and tolerance by coadministration of cAMP-related reagents with morphine, Methods Find. Exp. Clin. Pharmacol., 20, 619, 10.1358/mf.1998.20.7.485728 Iyo, 1996, Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram, Eur. J. Pharmacol., 312, 163, 10.1016/0014-2999(96)00479-7 Laschka, 1976, Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas, Psychopharmacologia, 46, 141, 10.1007/BF00421383 Ledeboer, 2007, Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes, Expert Opin. Investig. Drugs, 16, 935, 10.1517/13543784.16.7.935 Li, 2001, Adenosine enhances glial glutamate efflux via A2a adenosine receptors, Life Sci., 68, 1343, 10.1016/S0024-3205(00)01036-5 Madelian, 1996, Rapid regulation of a cyclic AMP-specific phosphodiesterase (PDE IV) by forskolin and isoproterenol in LRM55 astroglial cells, Biochem. Pharmacol., 51, 1739, 10.1016/0006-2952(96)00167-0 Mamiya, 2001, Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor, Br. J. Pharmacol., 132, 1111, 10.1038/sj.bjp.0703912 Menniti, 2006, Phosphodiesterases in the CNS: targets for drug development, Nat. Rev. Drug Discov., 5, 660, 10.1038/nrd2058 Mika, 2009, Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice, Brain Behav. Immun., 23, 75, 10.1016/j.bbi.2008.07.005 Narita, 2006, Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse, Neuropsychopharmacology, 31, 2476, 10.1038/sj.npp.1301007 Paxinos, 1998 Pothos, 1991, Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment, Brain Res., 566, 348, 10.1016/0006-8993(91)91724-F Raghavendra, 2004, Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats, Neuropsychopharmacology, 29, 327, 10.1038/sj.npp.1300315 Saud, 2005, Inhibition of TNF-alpha improves indomethacin-induced enteropathy in rats by modulating iNOS expression, Dig. Dis. Sci., 50, 1677, 10.1007/s10620-005-2914-0 Schubert, 2000, Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling, Ann. NY Acad. Sci., 903, 24, 10.1111/j.1749-6632.2000.tb06346.x Sebastiani, 2006, The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation, Neurobiol. Aging, 27, 691, 10.1016/j.neurobiolaging.2005.03.024 Si, 1998, Differential regulation of microglial activation by propentofylline via cAMP signaling, Brain Res., 812, 97, 10.1016/S0006-8993(98)00954-8 Sparrow, 1994, Inducible nitric oxide synthase in the central nervous system, J. Mol. Neurosci., 5, 219, 10.1007/BF02736723 Stella, 2003, Interactive role of adenosine and dopamine in the opiate withdrawal syndrome, Naunyn Schmiedebergs Arch. Pharmacol., 368, 113, 10.1007/s00210-003-0773-9 Streit, 1999, Reactive microgliosis, Prog. Neurobiol., 57, 563, 10.1016/S0301-0082(98)00069-0 Suzumura, 1999, Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS, Brain Res., 837, 203, 10.1016/S0006-8993(99)01666-2 Thompson, 2004, The type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice, Eur. J. Neurosci., 19, 2561, 10.1111/j.0953-816X.2004.03357.x Tzeng, 2005, Prostaglandins and cyclooxygenases in glial cells during brain inflammation, Curr. Drug Targets Inflamm. Allergy, 4, 335, 10.2174/1568010054022051 Tzschentke, 2007, Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addict. Biol., 12, 227, 10.1111/j.1369-1600.2007.00070.x van Calker, 2005, The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders, Neurochem. Res., 30, 1205, 10.1007/s11064-005-8792-1 Watkins, 2005, Glia: novel counter-regulators of opioid analgesia, Trends Neurosci., 28, 661, 10.1016/j.tins.2005.10.001 Watkins, 2007, Norman Cousins Lecture. Glia as the “bad guys”: implications for improving clinical pain control and the clinical utility of opioids, Brain Behav. Immun., 21, 131, 10.1016/j.bbi.2006.10.011 Wise, 1989, Opiate reward: sites and substrates, Neurosci. Biobehav. Rev., 13, 129, 10.1016/S0149-7634(89)80021-1 Wise, 1985, Brain mechanisms of drug reward and euphoria, Psychiatr. Med., 3, 445 Wu, 1995, Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons, J. Pharmacol. Exp. Ther., 273, 576 Yan, 2006, Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds, Behav. Brain Res., 173, 39, 10.1016/j.bbr.2006.05.029